TAp63 regulates bone remodeling by modulating the expression of TNFRSF11B/Osteoprotegerin.

Bone Remodeling Cell Differentiation Mesenchymal Stem Cells / metabolism Osteogenesis Osteoprotegerin / genetics
P63 breast mesenchymal stem cells osteogenic differentiation p53 family prostate cancer

Journal

Cell cycle (Georgetown, Tex.)
ISSN: 1551-4005
Titre abrégé: Cell Cycle
Pays: United States
ID NLM: 101137841

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 13 11 2021
medline: 8 4 2022
entrez: 12 11 2021
Statut: ppublish

Résumé

MSC, mesenchymal stem cells; OPG, osteoprotegerin; RUNX2, Run-trelated transcription factor 2.

Identifiants

DOI: 10.1080/15384101.2021.1985772 PMID: 34763601 PMC: PMC8794505
pubmed: 34763601
doi: 10.1080/15384101.2021.1985772
pmc: PMC8794505
doi:

Substances chimiques

Osteoprotegerin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2428-2441

Références

Onco Targets Ther. 2017 Jul 27;10:3801-3810
pubmed: 28794644
Horm Cancer. 2020 Aug;11(3-4):129-147
pubmed: 32592004
Oncogene. 2017 Apr 27;36(17):2377-2393
pubmed: 27869165
Horm Cancer. 2019 Dec;10(4-6):150-160
pubmed: 31317324
Br J Cancer. 2017 Jan 17;116(2):149-155
pubmed: 27884017
Cancer Treat Res. 2004;118:149-72
pubmed: 15043192
Horm Cancer. 2019 Jun;10(2-3):71-76
pubmed: 30989580
Horm Cancer. 2020 Feb;11(1):34-41
pubmed: 31865591
Mol Neurobiol. 2018 Apr;55(4):3237-3250
pubmed: 28478509
Mol Cancer. 2015 Jun 10;14:117
pubmed: 26054853
Nature. 1999 Jan 28;397(6717):315-23
pubmed: 9950424
Genes Dev. 1998 May 1;12(9):1260-8
pubmed: 9573043
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21093-8
pubmed: 22160687
J Cell Biol. 2006 Jan 2;172(1):115-25
pubmed: 16380437
Cell Stem Cell. 2009 Jul 2;5(1):64-75
pubmed: 19570515
Cell. 1997 Apr 18;89(2):309-19
pubmed: 9108485
Pathol Oncol Res. 2021 Apr 30;27:609472
pubmed: 34257573
J Exp Clin Cancer Res. 2019 Jan 8;38(1):12
pubmed: 30621730
Nat Cell Biol. 2014 Oct;16(10):1004-15, 1-13
pubmed: 25241036
Cell Death Differ. 2018 Jan;25(1):144-153
pubmed: 29077094
Mol Neurobiol. 2016 Sep;53(7):4509-20
pubmed: 26266644
Semin Cancer Biol. 2021 Jul;72:36-45
pubmed: 32619506
Nat Commun. 2021 Jan 15;12(1):383
pubmed: 33452256
Horm Cancer. 2020 Apr;11(2):76-86
pubmed: 32008217
Biol Direct. 2020 Oct 14;15(1):18
pubmed: 33054808
Nature. 1999 Apr 22;398(6729):708-13
pubmed: 10227293
J Clin Oncol. 2014 Jul 1;32(19):1979-86
pubmed: 24888802
Cancer Res. 2002 Mar 15;62(6):1619-23
pubmed: 11912131
Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):18952-7
pubmed: 24190996
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21099-104
pubmed: 22160706
Int J Mol Sci. 2019 May 31;20(11):
pubmed: 31159154
J Orthop Res. 2005 Nov;23(6):1345-53
pubmed: 15994055
Nat Med. 2007 Jul;13(7):791-801
pubmed: 17618270
Int J Mol Sci. 2021 Mar 05;22(5):
pubmed: 33807717
CA Cancer J Clin. 2017 Nov;67(6):439-448
pubmed: 28972651
Nat Rev Cancer. 2007 Mar;7(3):165-8
pubmed: 17332760
Horm Cancer. 2020 Aug;11(3-4):148-154
pubmed: 32519274
Nature. 2000 Mar 2;404(6773):99-103
pubmed: 10716451
J Natl Cancer Inst. 2011 Sep 21;103(18):1397-402
pubmed: 21753181
Cell Physiol Biochem. 2018;46(4):1423-1438
pubmed: 29689559
Cell Res. 2005 Jan;15(1):57-62
pubmed: 15686629
Cell Death Differ. 2021 Jan;28(1):156-169
pubmed: 32694652
J Mol Med (Berl). 2001 Jun;79(5-6):243-53
pubmed: 11485016
Cell. 2017 Sep 7;170(6):1062-1078
pubmed: 28886379
Arthritis Rheum. 1983 Feb;26(2):191-200
pubmed: 6186260
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Cancer Lett. 2017 Jul 1;397:103-110
pubmed: 28373003
Horm Cancer. 2019 Jun;10(2-3):64-70
pubmed: 30656558
J Cell Physiol. 2011 Mar;226(3):780-4
pubmed: 20857484
Nature. 1999 Apr 22;398(6729):714-8
pubmed: 10227294
Horm Cancer. 2020 Feb;11(1):17-33
pubmed: 31858384
Cell Death Differ. 2018 May;25(5):841-856
pubmed: 29229990
Anticancer Res. 2013 Jan;33(1):199-206
pubmed: 23267146
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3499-504
pubmed: 25739959
Cell. 1999 Oct 15;99(2):143-53
pubmed: 10535733
Pathol Oncol Res. 2012 Oct;18(4):743-7
pubmed: 22588706
Clin Cases Miner Bone Metab. 2008 Jan;5(1):49-56
pubmed: 22460846
Endocr Rev. 2000 Aug;21(4):393-411
pubmed: 10950158
Horm Cancer. 2020 Feb;11(1):13-16
pubmed: 31838715
Horm Cancer. 2020 Oct;11(5-6):218-239
pubmed: 32632815
Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11577-82
pubmed: 26324887
Front Immunol. 2019 Jun 19;10:1408
pubmed: 31275328
Cancer Cell. 2003 Jun;3(6):537-49
pubmed: 12842083
Mol Cell Biol. 2002 Dec;22(24):8659-68
pubmed: 12446784
Hum Mutat. 2014 Jun;35(6):702-14
pubmed: 24488880
Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15312-7
pubmed: 22949650
Comput Struct Biotechnol J. 2021 Jul 18;19:4101-4109
pubmed: 34527184
Virchows Arch. 2021 Feb;478(2):319-326
pubmed: 32661742
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Neuroscience. 2009 Feb 18;158(4):1378-89
pubmed: 19038313
Biochem Biophys Res Commun. 2010 Dec 3;403(1):13-7
pubmed: 20977890
Horm Cancer. 2020 Apr;11(2):87-96
pubmed: 32037484
Development. 2006 Jan;133(2):363-9
pubmed: 16368933
Endocrinology. 2007 Jun;148(6):2635-43
pubmed: 17395698
Cell Cycle. 2012 Oct 1;11(19):3638-48
pubmed: 22935697
Gene. 2004 Oct 27;341:19-39
pubmed: 15474285
Horm Cancer. 2020 Apr;11(2):63-75
pubmed: 31942683
Cell Death Differ. 2010 Dec;17(12):1816-29
pubmed: 21076477
Cell Cycle. 2010 Sep 15;9(18):3730-9
pubmed: 20855944
Oncotarget. 2014 Dec 30;5(24):12820-934
pubmed: 25514460

Auteurs

Anna Maria Lena (AM)

Department of Experimental Medicine, TOR, University of Rome "Tor Vergata", Rome, Italy.

Erica Foffi (E)

Department of Experimental Medicine, TOR, University of Rome "Tor Vergata", Rome, Italy.

Massimiliano Agostini (M)

Department of Experimental Medicine, TOR, University of Rome "Tor Vergata", Rome, Italy.
ORCID: 0000-0003-3124-2072

Mara Mancini (M)

IDI-IRCCS, Via dei Monti di Creta, Rome, IT.
ORCID: 0000-0001-5173-4854

Margherita Annicchiarico-Petruzzelli (M)

IDI-IRCCS, Via dei Monti di Creta, Rome, IT.

Daniel Aberdam (D)

University of Paris and INSERMU1138.

Tania Velletri (T)

Cogentech Società Benefit Srl, Parco Scientifico E Tecnologico Della Sicilia, Catania, Italy.

Yufang Shi (Y)

Cas Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
The First Affiliated Hospital of Soochow University, Institutes for Translational Medicine, Soochow University, Suzhou, China.

Gerry Melino (G)

Department of Experimental Medicine, TOR, University of Rome "Tor Vergata", Rome, Italy.
ORCID: 0000-0001-9428-5972

Ying Wang (Y)

Cas Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.

Eleonora Candi (E)

Department of Experimental Medicine, TOR, University of Rome "Tor Vergata", Rome, Italy.
IDI-IRCCS, Via dei Monti di Creta, Rome, IT.
ORCID: 0000-0001-8332-4825

Articles similaires

A key role for P2RX5 in brown adipocyte differentiation and energy homeostasis.

Maria Razzoli, Seth McGonigle, Bhavani Shankar Sahu et al.
1.00
Animals Adipocytes, Brown Mice Cell Differentiation Male

Synergistic effects of curcumin and stem cells on spinal cord injury: a comprehensive review.

Reza Arefnezhad, Arian Jahandideh, Mahdi Rezaei et al.
1.00
Curcumin Spinal Cord Injuries Humans Animals Neural Stem Cells

Stem cell-homing biomimetic hydrogel promotes the repair of osteoporotic bone defects through osteogenic and angiogenic coupling.

Fei-Long Wei, Yuan Zhai, Tian-Fu Wang et al.
1.00
Animals Osteogenesis Osteoporosis Mesenchymal Stem Cells Humans

Identification of CD141

Gabee Park, Dae Yeon Hwang, Do Young Kim et al.
1.00
Humans Mesenchymal Stem Cells Animals Mice Mesenchymal Stem Cell Transplantation

Classifications MeSH

questionsmedicales.fr › Phénomènes biologiques › Régénération › Remodelage osseux › TAp63 regulates bone remodeling by modulating...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Différenciation cellulaire › TAp63 regulates bone remodeling by modulating...
questionsmedicales.fr › Cellules › Cellules souches › Cellules souches multipotentes › Cellules souches mésenchymateuses › TAp63 regulates bone remodeling by modulating...
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système locomoteur › Développement locomoteur › Biominéralisation › Développement osseux › Ostéogenèse › TAp63 regulates bone remodeling by modulating...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Récepteurs aux cytokines › Récepteurs aux facteurs de nécrose tumorale › Récepteurs leurres aux facteurs de nécrose tumorale › Ostéoprotégérine › TAp63 regulates bone remodeling by modulating...